Pulmonary Disease, Chronic Obstructive Clinical Trial
Official title:
KOL-Fyn - an Explorative Study Wtih Telemedicine in COPD Patients at Home
Patients with COPD are often admitted to the hospital with an exacerbation. It is the most
common cause for admissions to medical wards. The patients are often readmitted. This is har
great impact on health economy and is a significant factor to medical beds.
The aim of this study was to investigate the effect of telemedicine consultations between
respiratory nurses at the hospital and COPD patients in their homes after a discharge from
the hospital, which was caused by an exacerbation.
Participants All patients admitted acutely to the medical ward for respiratory diseases at
Odense University Hospital, Svendborg from the 4th of June 2007 until the 15th of Marts 2008
and from the 8th of August 2008 until the 6th of January 2009 were candidates if they had
ECOPD defined as COPD with more dyspnoea, more cough and/or more sputum and a need for
increased medication. The inclusion and exclusion criteria as mentioned in eligibility
criteria.
The ECOPD patients included lived at Funen County, Denmark in the recruiting area of Odense
University Hospital, Svendborg. In order to further characterize the patients at baseline,
we retrieved data from the Funen County Patient Administrative System (FPAS) and the Odense
University Pharmacoepidemiological Database (OPED). In brief, FPAS holds discharge diagnoses
on all in-patient contacts in Funen County since 1973 and out-patient secondary care
contacts since 1989. Diagnoses are coded according to the ICD8 until 1993 and ICD10 from
1994. OPED is a research database that holds information on reimbursed prescription from
Funen County since 1990. All respiratory drugs are covered by the plan.
Interventions The telemedicine equipment consisted of a computer with web camera, microphone
and measurement equipment with one bottom to contact to the respiratory nurse at the
hospital and one alarm bottom. The nurse and the patient were able to see each other and to
talk together and the nurse was able to measure saturation and perform a spirometry. The
results were transferred to the hospital by a secure internet line. The equipment was
especially designed to the ECOPD patients in cooperation between the OUH, Svendborg Hospital
and a private company, Global IT Systems. Its popular name is "The Patient Suitcase".
Within 24 hours after the patient was discharged the telemedicine equipment was installed at
the patient's home by a technician, who also collected and cleaned the equipment after use.
The patients were included for four weeks followed by a visit to the outpatient clinic with
a doctor. The patient was planned to have the equipment for approximately one week and had
at least one follow-up phone call within the four weeks period. TVC could be made from 8 AM
to 3 PM every day. The patient could call the telemedicine department in the same period of
time.
During the TVC the nurse made clinical observations (i.e. dyspnoea, general condition,
physical activity, anxiety), measured saturation and lung function and informed the patients
how to prevent exacerbations and how to use the medication. Anxiety was estimated. The
telemedicine consultation was agreed on with the patient and the telemedicine nurse from day
to day. If the TVC patient were readmitted, the patient stopped with telemedicine
consultations and the telemedicine equipment was collected.
All ECOPD patients who fulfilled the inclusion criteria and none of the exclusion criteria
were consecutively divided into two groups due to home municipality. ECOPD patients who
lived in Svendborg or Faaborg-Midtfyn municipality were included in the TVC-group and ECOPD
patients from other municipalities were included in the control group.
Implementation Obviously, the study was not blinded. Every day between 8-9 AM all patients
admitted to the medical ward for respiratory diseases were screened by a nurse. Patients who
fulfilled the inclusion criteria's and none of the exclusion criteria's gave informed
consent.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|